Baker Department Seed Funding

The Baker Department of Cardiometabolic Health

Baker Department of Cardiometabolic Health Seed Funding

The Baker Department of Cardiometabolic Health funds an annual seed grant scheme aiming to foster collaborations between the University of Melbourne and the Baker Heart and Diabetes Institute. The focus of the grant applications needs to be on cardiometabolic health. The outcome must be impactful, and the collaborative team must provide a meaningful contribution to the Baker Department of Cardiometabolic Health. The establishment of successful teams will increase the potential to progress to successful externally funded grants.

Funding is available to a maximum of $200k per grant for a term of 12 months.

For more information, please contact


  1. Impactful research aligned with the goals of the Department 
  2. Meaningful contribution from a Baker Department of Cardiometabolic Health and University groups from different departments and faculties. A background of collaboration will be valued.
  3. The ability to outline a clear pathway to a grant application and include the target grant type and round (i.e. date) required.
  4. Maximum of 1 submission per Principal Investigator. Groups with a CIA on a current seed grant are ineligible.

Terms and Conditions

  • Investigators are to be appointed honoraries of the Baker Department of Cardiometabolic Health.
  • Submission of future competitive grants based on the seed funded project to be submitted via the Baker Department of Cardiometabolic Health.
  • An initial and final talk based on the project to be presented to the Department.

Projects awarded funding in previous years:


  • Structure-based development of novel anti-inflammatory drugs targeting C-reactive protein led by Professor Karlheinz Peter in collaboration with Professor Michael Parker, Dr Tracy Nero, Dr Steffi Shing, Dr Craig Morton, Associate Professor James McFadyen, Professor Geoff Pieterz, and Dr Guy Krippner. Awarded $200,000.
  • CAPLA trial led by  Professor Peter Kistler in collaboration with Professor Jonathan Kalman, Geoffrey Lee, Sandeep Prabhu, and Hariharan Sugumar. Awarded $100,000.
  • Atrial remodelling and risk of arrhythmias in endurance athletes led by Associate Professor Andre la Gerche in collaboration with Paul James, David Prior, Jon Kalman, and Diane Fatkin. Awarded $100,000.
  • Risk of heart failure in women following preeclampsia: is prevention possible? led by Professor Natalie Hannan in collaboration with Fiona Brownfoot, Joanne Said, Jonathan Sen, Morag Young, Daniel Donner, Helen Kiriazis. Awarded $100,000.
  • Acceptability and feasibility of risk guidance in acute myocardial infarction via a technology enabled disease management program led by Associate Professor Melinda Carrington in collaboration with Associate Professor Jo-Anne Manski-Nankervis, Professor Brian Oldenburg, Dr Dominika Kwasnicka and Dr Quan Huynh. Awarded $200,000.
  • PRogrEssion of Diabetic Complications (PREDICT) study led by Professor Jonathan Shaw in collaboration with Dr Mervyn Kyi, Associate Professor Shane Hamblin, Associate Professor Agus Salim and Dr Julian Scare.  Awarded $100,000.
  • Persistent Cardiovascular Effects of COVID-19 led by Dr Erin Howden in collaboration with Associate Professor Luke Burchill, Professor Graeme Maguire, Associate Professor Chiew Wong, Professor Jo Douglass, Dr Quan Huynh, Dr Leah Wright, A/Prof Andre La Gerche & Professor Tom Marwick.  Awarded $100,000.
  • Development of biodegradable and anti-thrombotic stents led by Professor Amanda Ellis in collaboration with Dr Daniel Heath, Dr Simone Hendriske, Dr Xiaowei Wang, Professor Geoffrey Pietersz, Dr James McFadyen, Dr Laura Bienvenu, Dr Smriti Krishna and Dr Jathushan Palasubramaniam. Awarded $100,000.


  • WITHDRAWal of heart failure directed therapies in recovered Atrial Fibrillation led by Associate Professor Sandeep Prabhu in collaboration with Professor Peter Kistler and Professor Jonathan Kalman. Awarded $100,000.


  • Multiomic investigation of mechanotransduction in calcific aortic valve disease  led by Associate Professor Sara Baratchi (Baker/RMIT/UoM) in collaboration with Nicholas Williamson, Ching-Seng Ang, Agus Salim, Karlheinz Peter, Jonathan Noonan, Nalin Dayawansa, Habiba Danish. Awarded $200,000.
  • Calculating internal clock time from blood transcriptomic data – evaluation of a universal biomarker for cardiovascular and metabolic disease led by Associate Professors Morag Young and Kegan Moneghetti (Baker/UoM) in collaboration with Sarah Gutman, David Prior, Jonathan Shaw, Peter Meikle, Tom Marwick. Awarded $100,000.
  • Comprehensive evaluation of plasma markers of PI3K activity in healthy and diseased hearts to identify future treatment strategies led by Associate Professor William Chan (UoM/Monash/Western Health) in collaboration with Kawa Haji, Julie McMullen. Awarded $100,000.